BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 27106113)

  • 1. Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.
    Mauro PM; Furr-Holden CD; Strain EC; Crum RM; Mojtabai R
    Drug Alcohol Depend; 2016 Jun; 163():108-15. PubMed ID: 27106113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of substance use disorder treatment in traditional mental health facilities: Timeseries and cross-sectional evaluations.
    Garrison YL; Luo Y; Sahker E
    Int J Drug Policy; 2024 Feb; 124():104312. PubMed ID: 38176176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Ettner SL;
    J Acquir Immune Defic Syndr; 2008 Apr; 47(4):449-58. PubMed ID: 18197121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment use, perceived need, and barriers to seeking treatment for substance abuse and mental health problems among older adults compared to younger adults.
    Choi NG; DiNitto DM; Marti CN
    Drug Alcohol Depend; 2014 Dec; 145():113-20. PubMed ID: 25456572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of Trauma-Specific Services in US Substance Use Disorder and Other Mental Health Treatment Facilities: 2015-2019.
    Spivak S; Spivak A; Decker MR; Cullen B; Yao M; Mojtabai R
    Psychiatr Q; 2022 Sep; 93(3):703-715. PubMed ID: 35612755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment.
    Evans E; Padwa H; Li L; Lin V; Hser YI
    J Subst Abuse Treat; 2015 Dec; 59():10-9. PubMed ID: 26321439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental health facilities with ketamine infusion therapy in the United States in 2020: Co-location of dual diagnosis mental health and substance use disorder treatment.
    Ware OD
    Exp Clin Psychopharmacol; 2024 Jun; 32(3):263-269. PubMed ID: 37917509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs.
    Shover CL; Abraham A; D'Aunno T; Friedmann PD; Humphreys K
    J Subst Abuse Treat; 2019 Oct; 105():44-50. PubMed ID: 31443890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.
    Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ
    Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment receipt patterns among individuals with co-occurring posttraumatic stress disorder (PTSD) and substance use disorders.
    Simpson TL; Hawrilenko M; Goldberg S; Browne K; Lehavot K; Borowitz M
    J Consult Clin Psychol; 2020 Nov; 88(11):1039-1051. PubMed ID: 32790452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic health record adoption among US substance use disorder and other mental health treatment facilities.
    Spivak S; Strain EC; Cullen B; Ruble AAE; Antoine DG; Mojtabai R
    Drug Alcohol Depend; 2021 Mar; 220():108515. PubMed ID: 33461154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special Services for Women in Substance Use Disorders Treatment: How Does the Department of Veterans Affairs Compare with Other Providers?
    Heslin KC; Gable A; Dobalian A
    Womens Health Issues; 2015; 25(6):666-72. PubMed ID: 26329259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of mental health and substance use disorder services integration among the workforce in primary care settings.
    Urada D; Schaper E; Alvarez L; Reilly C; Dawar M; Field R; Antonini V; Oeser B; Crèvecoeur-MacPhail D; Rawson RA
    J Psychoactive Drugs; 2012; 44(4):292-8. PubMed ID: 23210377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation.
    Wen H; Cummings JR; Hockenberry JM; Gaydos LM; Druss BG
    JAMA Psychiatry; 2013 Dec; 70(12):1355-62. PubMed ID: 24154931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance Use Disorder Treatment Services for Women in the Veterans Health Administration.
    Timko C; Hoggatt KJ; Wu FM; Tjemsland A; Cucciare M; Rubin A; Simpson TL
    Womens Health Issues; 2017; 27(6):639-645. PubMed ID: 28602581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between U.S. substance abuse treatment facilities that do and do not offer domestic violence services.
    Cohn A; Najavits LM
    Psychiatr Serv; 2014 Apr; 65(4):504-10. PubMed ID: 24430366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of mental health and substance use disorder treatment use over 3 years among rural adults using stimulants.
    Cucciare MA; Ounpraseuth ST; Curran GM; Booth BM
    Subst Abus; 2019; 40(3):363-370. PubMed ID: 30810499
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of co-occurring addictions, posttraumatic stress disorder, and major depressive disorder in detoxification treatment seekers: Implications for improving detoxification treatment outcomes.
    Anderson RE; Hruska B; Boros AP; Richardson CJ; Delahanty DL
    J Subst Abuse Treat; 2018 Mar; 86():45-51. PubMed ID: 29415850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining facilitative services for entry into substance use disorder treatment: A cluster analysis of treatment facilities.
    Amoako EO; Zerden LD; Hughes TD; Gertner AK; Williams J; Belden CM; Ware OD
    PLoS One; 2024; 19(5):e0304094. PubMed ID: 38781169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.